Enact Holdings, Inc. filings document the formal disclosures of a U.S. private mortgage insurance company. Form 8-K reports furnish quarterly and annual operating results, press releases, and financial supplements covering mortgage insurance performance, capital sufficiency, insurance in force, book value, and related financial measures.
The company's regulatory filings also cover proxy governance, board and stockholder voting matters, executive compensation, capital-return actions, stock repurchase arrangements involving Genworth Financial, and financing agreements such as its revolving credit facility. These records describe Enact's public-company governance, capital structure, liquidity arrangements, and material events tied to its mortgage insurance operations.
Enact Holdings, Inc. President and CEO Rohit Gupta reported equity compensation activity. On February 9, 2026, 31,762 restricted stock units converted into the same number of Enact common shares, a non-cash derivative exercise. The company then withheld 10,348 shares at $42.39 per share to cover related tax obligations. After these transactions, Gupta directly owned 391,169 shares of Enact common stock.
Enact Holdings, Inc. controller James McMullen reported equity compensation activity involving restricted stock units and common stock. On February 9, 2026, 967 restricted stock units converted into 967 shares of common stock on a 1:1 basis, increasing his directly held common stock to 3,099 shares.
The company then withheld 327 shares of common stock at a price of $42.39 per share to cover tax obligations related to the vesting, reducing his directly held balance to 2,772 shares. The restricted stock units vest and convert to common stock in three equal annual installments beginning on February 9, 2024.
Robert Restrepo has filed a notice of proposed sale of 5,000 shares of the issuer’s common stock on NASDAQ through Fidelity Brokerage Services LLC. The filing lists an aggregate market value of $214,750.00 for these shares and an approximate sale date of February 11, 2026. As context, the number of common shares outstanding is shown as 144,395,767. Restrepo acquired the 5,000 shares in an open market purchase from the issuer on September 16, 2021, paid in cash.
The notice also discloses that during the past three months, Restrepo sold 2,562 and 7,438 common shares on November 18 and 19, 2025, for gross proceeds of $95,848.92 and $278,106.82, respectively. By signing, the seller represents that he is not aware of undisclosed material adverse information about the issuer’s operations.
Enact Holdings, Inc. filed a current report describing new capital actions and recent results communications. The company’s board approved a share repurchase program for up to $500 million of outstanding common stock and entered into a stock repurchase agreement with Genworth Financial, Inc.
Enact also furnished a press release and financial supplement covering its financial results for the quarter ended December 31, 2025. These materials, along with a press release on the repurchase program and dividend declaration, are provided as exhibits and are furnished rather than filed under securities laws.
Genworth Holdings, Inc., a major shareholder of Enact Holdings, Inc., reported selling 634,953 shares of Enact common stock on January 30, 2026. The sale was made to Enact under a previously signed Share Repurchase Agreement at a price of $39.3661 per share.
After this transaction, Genworth Holdings beneficially owns 114,588,830 Enact common shares, which represents approximately 81% of Enact’s outstanding common stock. The transaction reflects an internal share repurchase arrangement rather than an open-market sale to third-party investors.
Enact Holdings, Inc. reported that one of its directors acquired 165 deferred stock units on December 11, 2025 through reinvestment of a cash dividend paid at $0.21 per share.
These deferred stock units become payable in shares of common stock one year after the director’s service as a director ends. After this transaction, the director beneficially owns 30,543.457 deferred stock units, held directly and recorded at a price of $0 per unit.
Enact Holdings, Inc. reported that one of its directors acquired 165 deferred stock units on December 11, 2025 through dividend reinvestment at $0.21 per share. These deferred stock units will be paid out in shares of common stock one year after the director’s board service ends.
After this transaction, the director beneficially owns 30,543.457 deferred stock units, held directly.
Enact Holdings, Inc. reported that one of its officers, serving as Controller, acquired additional restricted stock units (RSUs) tied to existing equity awards. The RSUs were credited on December 11, 2025 under dividend reinvestment terms connected to a quarterly cash dividend of $0.21 per share.
Each restricted stock unit is structured to settle into one share of common stock on a 1:1 basis. The affected RSU awards vest and convert to common stock in three equal annual installments, with different grants beginning on February 9, 2024, February 16, 2025, April 1, 2025, February 21, 2026, and October 1, 2026. The transactions were reported as acquisitions at a $0 exercise price, reflecting their nature as stock-based compensation rather than open-market purchases.
Enact Holdings, Inc. reported that an officer serving as EVP and Chief Risk Officer acquired additional restricted stock units on December 11, 2025. The filing shows three small additions of 16, 27 and 33 restricted stock units, each settling into one share of common stock and credited at a price of $0 under existing awards.
Footnotes explain that these extra units were issued under dividend reinvestment terms following a quarterly cash dividend of $0.21 per share paid on December 11, 2025. The related restricted stock unit awards vest in three equal annual installments beginning on February 9, 2024, February 16, 2025 and February 21, 2026.
Enact Holdings, Inc. reported an insider equity change involving one of its directors. On December 11, 2025, the director acquired 31 deferred stock units through dividend reinvestment tied to a $0.21 per share dividend. These deferred stock units are payable in shares of common stock one year after the director’s service ends. Following this transaction, the director beneficially owns 5,688.256 deferred stock units.